Reflect Scientific, Inc. (RSCF)
0.0454
-0.01
(-12.36%)
USD |
OTCM |
Aug 25, 16:00
Reflect Scientific Enterprise Value : 2.459M for Aug. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 25, 2026 | 2.459M |
| August 24, 2026 | 3.007M |
| August 21, 2026 | 3.016M |
| August 20, 2026 | 2.832M |
| August 19, 2026 | 2.832M |
| August 18, 2026 | 2.832M |
| August 17, 2026 | 2.832M |
| August 14, 2026 | 2.596M |
| August 13, 2026 | 3.024M |
| August 12, 2026 | 2.339M |
| August 11, 2026 | 1.876M |
| August 10, 2026 | 1.876M |
| August 07, 2026 | 1.911M |
| August 06, 2026 | 1.911M |
| August 05, 2026 | 1.825M |
| August 04, 2026 | 1.851M |
| August 03, 2026 | 1.876M |
| July 31, 2026 | 1.953M |
| July 30, 2026 | 2.125M |
| July 29, 2026 | 2.339M |
| July 28, 2026 | 2.082M |
| July 27, 2026 | 2.039M |
| July 24, 2026 | 2.039M |
| July 23, 2026 | 2.228M |
| July 22, 2026 | 2.168M |
| Date | Value |
|---|---|
| July 21, 2026 | 2.168M |
| July 20, 2026 | 2.082M |
| July 17, 2026 | 2.060M |
| July 16, 2026 | 2.060M |
| July 15, 2026 | 2.013M |
| July 14, 2026 | 2.234M |
| July 13, 2026 | 2.018M |
| July 10, 2026 | 2.018M |
| July 09, 2026 | 2.245M |
| July 08, 2026 | 2.082M |
| July 07, 2026 | 2.082M |
| July 06, 2026 | 2.202M |
| July 02, 2026 | 2.168M |
| July 01, 2026 | 2.168M |
| June 30, 2026 | 1.996M |
| June 29, 2026 | 1.855M |
| June 26, 2026 | 2.026M |
| June 25, 2026 | 2.026M |
| June 24, 2026 | 1.863M |
| June 23, 2026 | 1.863M |
| June 22, 2026 | 2.197M |
| June 18, 2026 | 2.30M |
| June 17, 2026 | 2.30M |
| June 16, 2026 | 2.505M |
| June 15, 2026 | 2.583M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| West Pharmaceutical Services, Inc. | 24.41B |
| Agilent Technologies, Inc. | 45.23B |
| Anika Therapeutics, Inc. | 273.23M |
| Bio-Rad Laboratories, Inc. | 10.19B |
| Bruker Corp. | 10.32B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.0928M |
| Revenue (Quarterly) | 0.4162M |
| Total Expenses (Quarterly) | 0.3234M |
| EPS Diluted (Quarterly) | 0.0011 |
| Gross Profit Margin (Quarterly) | 42.89% |
| Profit Margin (Quarterly) | 22.30% |
| Earnings Yield | 8.37% |
| Operating Earnings Yield | 6.93% |
| Normalized Earnings Yield | 8.37 |